文献速递其他结缔组织病

2019年OMERACT超声评分系统评估大唾液腺对干燥综合征的诊断性能

Diagnostic Performances of Ultrasound Evaluation of Major Salivary Glands According to the 2019 Outcome Measures in Rheumatology Ultrasound Scoring System.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-08-05

US-SG诊断干燥综合征的AUC为0.751(95%CI 0.621, 0.882),将US-SG纳入ACR/EULAR 2016标准后敏感性从89.4%升至91.5%、特异性从100%降至96.0%,AUC达0.975(95%CI 0.945, 1.00)。观察者间重复性良好(κ=0.73 [95%CI 0.64, 0.81])。

要点

  • US-SG(OMERACT评分≥2)诊断干燥综合征的AUC为0.751(95%CI 0.621, 0.882)。
  • US-SG纳入ACR/EULAR 2016标准后敏感性91.5%、特异性96.0%,AUC 0.975。
  • 观察者间重复性良好,κ=0.73(95%CI 0.64, 0.81)。

核心结论

  • 2019年OMERACT US-SG分类措施对干燥综合征诊断具有良好特异性,且在日常实践中可行。

研究设计与样本

  • 以ACR/EULAR 2016标准(评分≥4且不含眼染色评分)、AECG 2002标准及临床专家诊断为参照标准。
  • 由2名独立阅片者采用2019年OMERACT US评分系统评估,评分≥2定义为US-SG诊断干燥综合征。

主要发现

  • US-SG诊断干燥综合征(以ACR/EULAR 2016为标准)的AUC为0.751(95%CI 0.621, 0.882)。
  • 将US-SG纳入ACR/EULAR 2016标准后敏感性91.5% vs 89.4%、特异性96.0% vs 100%,AUC 0.975(95%CI 0.945, 1.00)。
  • 将US-SG纳入AECG 2002标准后观察到相似结果。
  • 小唾液腺组织学淋巴细胞浸润与US-SG的OMERACT分级相关。

关键数值与推荐

  • US-SG诊断干燥综合征定义为2019年OMERACT US评分≥2(2名独立阅片者)。
  • ACR/EULAR 2016分类标准评分≥4(不含眼染色评分)作为参照标准之一。
  • US-SG诊断干燥综合征的AUC为0.751(95%CI 0.621, 0.882)。
  • US-SG纳入ACR/EULAR 2016标准后AUC为0.975(95%CI 0.945, 1.00),敏感性91.5%、特异性96.0%。
  • US-SG诊断观察者间重复性κ=0.73(95%CI 0.64, 0.81)。

临床怎么用

  • 可将2019年OMERACT US-SG评分作为干燥综合征的辅助诊断工具,评分≥2支持诊断。
  • 在ACR/EULAR 2016分类标准基础上加入US-SG可轻微提高敏感性,但需注意特异性轻度下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the diagnostic performance of ultrasound examination of the salivary glands (US-SG) according to the 2019 Outcome Measures in Rheumatology (OMERACT) US scoring system for Sjögren's syndrome (SS). METHODS: The present work was a retrospective study based on a multicentric cohort with SS/sicca syndrome. The American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) 2016 classification criteria for SS (a score of ≥4 without ocular staining score), the American-European Consensus Group (AECG) 2002 classification criteria, and clinician experts were considered as reference standards for diagnosis of SS. An OMERACT score of ≥2 according to 2 independent readers defined the diagnosis of SS based on US-SG assessment. Diagnostic performances and interobserver reproducibility of US-SG were assessed. RESULTS: Forty-two patients fulfilling the ACR/EULAR 2016 criteria for SS were compared to 30 control subjects with sicca syndrome. Twenty-five patients were diagnosed as having SS according to US-SG evaluation, and they were more frequently observed in the SS group (52.5%) than in the control group (10.0%) (P < 0.001). US-SG showed an area under the curve (AUC) of 0.751 (95% confidence interval [95% CI] 0.621, 0.882) for the diagnosis of SS (ACR/EULAR 2016 classification). The inclusion of US-SG in the ACR/EULAR 2016 classification improved sensitivity (91.5% versus 89.4%) with limited decrease of specificity (96.0% versus 100%) and with an AUC of 0.975 (95% CI 0.945, 1.00). Similar results were observed when US-SG was included in the AECG 2002 classification criteria. Interobserver reproducibility of a score of ≥2 according to the 2019 OMERACT US scoring system for SS diagnosis was good (κ = 0.73 [95% CI 0.64, 0.81]). Histologic lymphocyte infiltration of the minor salivary glands was associated with the OMERACT grading of US-SG. CONCLUSION: The present study confirms the good specificity of the 2019 OMERACT US classification measures of US-SG for the diagnosis of SS and its feasibility in daily practice.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Robin F, Albert JD, Lescoat A, et al. Diagnostic Performances of Ultrasound Evaluation of Major Salivary Glands According to the 2019 Outcome Measures in Rheumatology Ultrasound Scoring System. Arthritis Care Res (Hoboken). 2022. PMID: 33973395. doi:10.1002/acr.24631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。